Abstract. To determine if genetic diversity of Blastocystis hominis exists in Japan, we monitored 64 B. hominisinfected people: 39 asymptomatic people whose infections were detected during routine medical check-ups (32 Japanese and 7 non-Japanese) and 25 patients with gastrointestinal symptoms who visited the outpatient clinics of St. Luke's International Hospital (19 Japanese and 6 non-Japanese). We detected 6 known and 2 new riboprint patterns in isolates from the infected people. There were no differences in the distribution of ribodemes between isolates from Japanese and non-Japanese people, similar to that in other countries. However, we noted a possible relationship between ribodeme type and pathogenicity. The results suggest that ribodemes I, III, and VI may be responsible for gastrointestinal symptoms.
INTRODUCTION
Brumpt 1 in 1912 reported that Blastocystis hominis was a harmless intestinal parasite. Since then, the organism has been found on numerous occasions in the human intestinal tract. 2, 3 Although most cases of B. hominis infection are asymptomatic, symptomatic infections have been reported, and the pathogenicity of this unicellular organism remains controversial. [2] [3] [4] [5] [6] Although recent genetic analyses have revealed the existence of B. hominis subspecies, [7] [8] [9] [10] [11] [12] [13] a definite correlation between genetic makeup and pathogenicity has not yet been found. To characterize the subspecies present in Japan, we monitored the genetic diversity of B. hominis isolates by riboprinting and restriction fragment length polymorphism analysis of polymerase chain reaction-amplified small-subunit rDNA. 11 
MATERIALS AND METHODS

Organisms.
A total of 64 B. hominis isolates were collected from people living in Japan. Thirty-nine symptomfree people (32 Japanese and 7 non-Japanese) came to the Health Screening Center of St. Luke's International hospital in Tokyo for a regular annual physical check-up during October 1994-October 1995. Twenty-five patients (19 Japanese and 6 non-Japanese) with gastrointestinal (GI) symptoms visited a walk-in clinic during October 1994-October 1996. Stool samples from all patients with GI symptoms were cultured for Campylobacter, Shigella, Salmonella, Yersinia, Vibrio, and pathogenic Escherichia coli and examined by a direct wet film for ova and parasites before any medical treatment was given. The stool samples were collected either at the hospital or at home and brought to the hospital as soon as possible in containers supplied by the hospital. The microscopic diagnosis of B. hominis was confirmed by culture in Locke-Egg (LE) medium 14, 15 in the hospital laboratory. All isolates were cultured at 37ЊC in LE culture medium and subcultured every 3 or 4 days.
All Blastocystis-positive patients with GI symptoms received a colonoscopic examination after providing informed consent as part of a complete medical work-up. All patients except one were followed up every 2 months; patients were interviewed and physical and stool examinations were performed. The patients' symptoms abated after a reduction in the number of B. hominis, even in untreated people. After specific treatment with metronidazole, all complaints ceased.
DNA isolation. Blastocystis hominis grown in LE medium was isolated by centrifugation with 20% Percoll and then lysed by shaking for 2 hr at 60ЊC in lysis buffer (100 mM NaCl, 10 mM Tris, 10 mM ethylenediaminetetraacetic acid, 0.5% sodium N-lauroly sarcosinate, and 0.5 mg proteinase K/mL). DNA extraction was performed with phenol/chloroform/isoamyl alcohol and ethanol precipitated with sodium acetate according to a procedure previously described. 16 Polymerase chain reaction (PCR). Amplification of DNA was carried out under standard PCR conditions, with the primers RD5 GGAAGCTTATCTGGTTGATCCTGCC-AGTA and RD3 GGGATCCTGATCCTTCCGCAGGTCA-CCTAC, as described by Clark. 11 The 35-cycle PCR consisted of denaturation (93ЊC) for 1 min (3 min in cycle 1), annealing (55ЊC) for 2 min, and polymerization (72ЊC) for 2 min. The yield was estimated by running an aliquot of the amplification products on an analytic agarose gel (0.8%). Electrophoretic patterns of the products are shown in Figure  1 . No bands originating from coexisting bacteria were observed.
Restriction-endonuclease digestion. The amplification products were digested with 3 restriction enzymes (HinfI, RsaI, and Sau3AI) and the restriction digests electrophoresed in 2% agarose gels containing ethidium bromide. The presence of specific bands was visualized under ultraviolet light. The restriction fragment patterns obtained for each ribodeme were analyzed and classified into 7 distinct ribodemes, as described by Clark. 11 Statistical analysis. The chi-square test 17 was used to compare the prevalence of ribodemes of B. hominis isolates from symptomatic and asymptomatic people.
RESULTS
Riboprint patterns of 64 isolates of B. hominis were obtained with PCR and digestion with restriction endonucleases HinfI (Figure 2A) , RsaI ( Figure 2B ), or Sau3AI ( Figure  2C ). The results are summarized in Table 1 . Six known and 2 new patterns were identified (Table 1) ; ribodeme II was the most common. Ribodeme V was not detected in either Japanese or non-Japanese people living in Japan. Two new ribodemes, types VIII and IX, were observed in 3 isolates Colonoscopic examination of the B. hominis-infected people revealed inflammatory changes in the intestinal mucosa in 5 people with GI symptoms. In the other 11 people with symptoms, intestinal lesions were not seen.
Interestingly, in the Japanese group, we detected an asymptomatic married couple infected with isolates possessing different ribodemes. The wife was infected with a type II ribodeme isolate, and the husband was infected with a type I ribodeme isolate. This observation indicates that epidemiologically, transmission of the organism by intimate contact is of little or no importance, as previously discussed in our epidemiological survey. 18 
DISCUSSION
Asymptomatic and symptomatic B. hominis infections in humans have been reported worldwide. 3 It is generally accepted that B. hominis is transmitted by the fecal-oral route, in a manner similar to other GI protozoa. 2, 19, 20 Hahn and Fleischer 21 suggested that B. hominis frequently is acquired during travel to tropical countries.
In Japan, very few cases of B. hominis infection with symptoms have been reported. Our recent epidemiologic survey confirmed the presence of the parasite in Japan, although its prevalence is quite low. 18 The wide geographic distribution of B. hominis is also indicated by the present study because there were no obvious differences in riboprint patterns of isolates from Japanese and non-Japanese patients and between the present results and those of Clark. 11 Ribodeme II was the most frequently isolated variant of B. hominis, ribodemes IV and VII were rare, and ribodeme V failed to appear.
It is unknown whether B. hominis is a true pathogen or a commensal one. The organism is found in the stool of both healthy people and in patients with GI symptoms. This paradoxical observation is explained by the hypothesis that different types of B. hominis, exhibiting similar morphological features but with a different pathological potential, may exist. Indeed, several studies have already pointed out the existence of genetic and molecular diversity in human strains of Blastocystis. 8, 11, 12, [22] [23] [24] [25] However, antigenic, isoenzymatic, or genetic differences do not appear to be related to pathogenicity of the organism. The present study indicates that genetic diversity exists among organisms isolated from people residing in Japan. Tables 1 and 2 illustrate the possible relationship between pathogenicity of the organism and ribodemes. Table 2 is a condensed version of Table 1 and combines data from Japanese and non-Japanese patients. As shown in Table 2 , the isolates from symptomatic people with B. hominis infection had ribodemes I, II, III, or VI. In relating the appearance of GI symptoms with ribodeme types, ribodemes I, III, and VI were significantly more common than ribodeme II (P Ͻ 0.05). Furthermore, Clark 11 stated that the sequence divergence between the small-subunit rDNA of ribodemes I and II is Ͼ7% and that genetic distances between ribodemes I and VI are even closer.
Therefore, the present results suggest that ribodemes I, III, and VI are factors contributing to the symptoms of blastocystosis. However, it is unlikely that GI symptoms are due only to pathogenic variants. We performed colonoscopies in all patients with GI symptoms within 1 week after finding the organism and detected inflammatory changes (mucosal erosion and edema) in 5 people whose isolates exhibited ribodemes III and VI ( Table 2) . As Garavelli and others 26 and Zierdt 2 have pointed out, it is possible that nonspecific inflammation of the intestinal mucosa, without invasion or adhesion of the parasite, may be caused by a toxic-allergic reaction to B. hominis. It is unclear whether or not variants of B. hominis with ribodemes I, III, or VI are causative agents for making inflammatory lesions. Therefore, further investigation is required along these lines. I  II  III  IV  V  VI  VII  VIII  IX  Total   5 Jpn ϭ Japanese. Non-Jpn ϭ Non-Japanese. GI ϭ gastrointestinal. 
